Mineralocorticoid Receptor Antagonists: Are They All Created Equal?
Drs Rossing, Wanner, and Zannad discuss the potential role of MRAs in slowing CKD progression in patients with T2D.
Earn Credit / Learning Objectives & Disclosures
---
Full URLs:
Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/922328?src=mkm_podcast_addon_922328
Create your
podcast in
minutes
It is Free